Investigating the role of USP11 in tau regulation and Alzheimer's disease

Deubiquitinase USP11 in tau regulation and age-related tauopathy

NIH-funded research Case Western Reserve University · NIH-10814242

This study is looking at how a protein called USP11 affects another protein linked to Alzheimer's disease, called tau, by using mice and human brain samples, to help us understand how these proteins interact and what that means for brain health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-10814242 on NIH RePORTER

What this research studies

This research focuses on understanding how the protein USP11 affects tau, a key protein involved in Alzheimer's disease. By studying mouse models and human brain tissues, the researchers aim to uncover how USP11 influences tau's stability and aggregation, which are critical factors in the development of neurodegenerative diseases. The approach includes various advanced techniques such as imaging, biochemical assays, and behavioral studies to explore the relationship between USP11 and tau pathology across different ages and sexes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease, particularly those with age-related cognitive decline.

Not a fit: Patients with tauopathies unrelated to Alzheimer's disease or those without cognitive impairments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease by targeting tau regulation.

How similar studies have performed: Previous research has shown promising results in targeting tau pathology, suggesting that this approach could yield significant insights into Alzheimer's disease.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.